Google Chrome
Safari
Firefox
Edge
Article / Feb 01, 2014
Particle Engineering for Inhaled Therapeutics
Pharmaceutical Technology Europe, February 2014
Search
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Press Release / Sep 06, 2022
Hovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting
Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services.
Press Clipping / May 03, 2023
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Analytical Characterization
Hovione advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Release / Mar 07, 2018
Hovione sells the iMAX business
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
Article / Apr 30, 2010
Inhalation: Going Beyond Asthma. Interview: Peter Villax and Jason Suggett
Drug Delivery Technology, April 2010